NEW YORK, April 11 – Microbead maker Lynx Therapeutics seems to have finally succeeded in getting its message out to the market.

Wednesday, the company announced the latest in a recent string of deals for its Megaclone bead technology, used in gene expression studies. This agreement, in which Lynx will genotype RNA from different varieties of the Tilapia fish for Norwegian marine genomics company GenoMar, is the fifth commercial collaboration Lynx has announced since the end of February.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.